Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24‐month interim analysis of a long‐term post‐marketing study (J‐STEP/LT)

AIMS/INTRODUCTION: Tofogliflozin is a potent and highly selective sodium–glucose cotransporter 2 inhibitor, and is currently used to treat patients with type 2 diabetes mellitus. We designed a 3‐year study of tofogliflozin in patients with type 2 diabetes mellitus to evaluate the safety and effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Utsunomiya, Kazunori, Kakiuchi, Seigo, Senda, Masayuki, Fujii, Shoko, Kurihara, Yuji, Gunji, Ryoji, Koshida, Ryusuke, Kameda, Hiroyuki, Tamura, Masahiro, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378444/
https://www.ncbi.nlm.nih.gov/pubmed/32034997
http://dx.doi.org/10.1111/jdi.13233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378444/
https://www.ncbi.nlm.nih.gov/pubmed/32034997
http://dx.doi.org/10.1111/jdi.13233

Ejemplares similares